Effect of Proton Pump Inhibitor on Esophageal Eosinophilia

被引:58
|
作者
Schroeder, Shauna
Capocelli, Kelley E. [2 ]
Masterson, Joanne C.
Harris, Rachel
Protheroe, Cheryl [3 ]
Lee, James J. [3 ]
Furuta, Glenn T. [1 ]
机构
[1] Univ Colorado, Childrens Hosp Colorado, Sect Pediat Gastroenterol Hepatol & Nutr, Digest Hlth Inst,Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Sch Med, Gastrointestinal Eosinophil Dis Program, Denver, CO USA
[3] Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ USA
关键词
eosinophil; eosinophil peroxidase; gastroesophageal reflux disease; histopathology; GASTROESOPHAGEAL-REFLUX DISEASE; CONSENSUS RECOMMENDATIONS; PEDIATRIC-PATIENTS; FOOD IMPACTION; CHILDREN; DIAGNOSIS; THERAPY;
D O I
10.1097/MPG.0b013e3182716b7a
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Differentiation between the common etiologies of dense esophageal eosinophilia such as gastroesophageal reflux disease (GERD) and eosinophilic esophagitis can be difficult. We hypothesized that histologic features may provide diagnostic clues concerning the etiology of esophageal eosinophilia. Methods: We performed a retrospective chart review of 204 children with the diagnosis of esophagitis characterized by >= 15 eosinophils (eos) per high-power field (HPF) in at least 1 biopsy. We then restricted our analysis to subjects who had received at least 8 weeks of only proton pump inhibitors (PPIs) followed by endoscopy and who had a clinicopathologic response to this treatment. Symptoms, endoscopic findings, and pathologic descriptions were reviewed and an eosinophil peroxidase (EPX) index was determined to assess for degranulation/eosinophil activation. Results: Of the 204 identified charts, 7 subjects identified met the inclusion criteria. Five of these 7 patients showed a clinicopathologic response to PPIs after their follow-up endoscopy, (mean peak eosinophil count: 92 vs 5 eos/HPF, and EPX index: 39.2 vs 14.6, pre- and posttreatment, respectively). Two patients experienced initial resolution of symptoms and esophageal eosinophilia with PPI therapy; however, within 17-23 months they redeveloped symptoms and esophageal eosinophilia while receiving PPI therapy at the time of a third endoscopy (mean peak eosinophil count: 40 vs 11 vs 36 eos/HPF, and EPX index: 44 vs 21 vs 36.5, pre-, post- and posttreatment, respectively). No clinicopathologic features or degranulation patterns differentiated subjects with GERD/PPI responsive esophageal eosinophilia from those who had transient response to PPI treatment. Conclusions: No clinicopathologic features differentiated subjects who responded to PPI treatment. PPI treatment can be helpful to exclude GERD and PPI responsive esophageal eosinophilia but long-term follow-up is critical in the management of esophagitis.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 50 条
  • [1] Proton-pump inhibitor-responsive esophageal eosinophilia
    Molina-Infante, Javier
    Katzka, David A.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (04) : 428 - 433
  • [2] Esophageal hyperkeratosis after proton pump inhibitor therapy in a patient with esophageal eosinophilia
    Molina-Infante, Javier
    Ferrando-Lamana, Lucia
    Vinagre-Rodriguez, Gema
    [J]. GASTROINTESTINAL ENDOSCOPY, 2013, 77 (01) : 131 - 132
  • [3] PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPHAGEAL SYMPTOMS BY RESTORING A NORMAL ESOPHAGEAL PERISTALSIS IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA
    Della Coletta, Marco
    de Bortoli, Nicola
    Bartolo, Ottavia
    Tolone, Salvatore
    Bodini, Giorgia
    Marabotto, Elisa
    Zentilin, Patrizia
    Savarino, Vincenzo
    Savarino, Edoardo V.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S860 - S860
  • [4] Proton pump inhibitor therapy improves esophageal symptoms by restoring a normal esophageal peristalsis in patients with proton pump inhibitor-response esophageal eosinophilia
    della Coletta, M.
    de Bortoli, N.
    Bartolo, O.
    Tolone, S.
    Savarino, V.
    Savarino, E.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 : 10 - 11
  • [5] Proton pump inhibitor therapy improves esophageal symptoms by restoring a normal esophageal peristalsis in patients with proton pump inhibitor-response esophageal eosinophilia
    Della Coletta, M.
    de Bortoli, N.
    Bartolo, O.
    Tolone, S.
    Bodini, G.
    Marabotto, E.
    Zentilin, P.
    Savarino, V.
    Savarino, E.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 : 29 - 29
  • [6] Proton pump inhibitor responsive esophageal eosinophilia,a distinct disease entity?
    William Munday
    Xuchen Zhang
    [J]. World Journal of Gastroenterology, 2014, 20 (30) : 10419 - 10424
  • [7] Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
    Munday, William
    Zhang, Xuchen
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (30) : 10419 - 10424
  • [8] ESOPHAGEAL DISTENSIBILITY IN PROTON PUMP INHIBITOR RESPONSIVE ESOPHAGEAL EOSINOPHILIA IS DECREASED COMPARED TO CONTROLS
    Lynch, Kristle L.
    Benitez, Alain
    Kluger, Jonathan
    DeMarshall, Maureen
    Falk, Gary W.
    Muir, Amanda B.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S700 - S700
  • [10] Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy
    DiGiovanni, Ernest L.
    Champeaux, Anne L.
    Arroyo, May R.
    Richter, Joel E.
    [J]. ACG CASE REPORTS JOURNAL, 2016, 3 (02) : 95 - 97